Unlike M100 (which provides “S/I/R” breakpoints for many drugs), M45 often provides only MIC ranges or “provisional breakpoints” due to limited data. Labs must report results with interpretive comments.
Some medical libraries may loan a print copy, but PDFs cannot be legally shared due to DRM restrictions. clsi document m45 pdf
Unlike M100, M45 does not always provide “S/I/R” (Susceptible/Intermediate/Resistant) breakpoints for every drug-organism pair due to limited clinical data. Instead, you may find: Unlike M100 (which provides “S/I/R” breakpoints for many
In the complex world of clinical microbiology, standard susceptibility testing methods (like those outlined in CLSI M100) work well for common pathogens such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. However, what happens when a laboratory encounters a rare, fastidious, or unusual organism that does not grow well under routine conditions? Unlike M100, M45 does not always provide “S/I/R”
Enter the CLSI document M45. Officially titled "Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria," this guideline is an indispensable resource for clinical microbiologists, infectious disease specialists, and laboratory professionals. If you have been searching for the CLSI document M45 PDF, you are likely looking for standardized, evidence-based methods to handle these challenging pathogens.
This article provides a deep dive into the M45 document—its purpose, history, key content, how to obtain a legitimate PDF, and why it remains the "gold standard" for unusual organism testing.